Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $341.43 million. The enterprise value is $421.26 million.

Market Cap	341.43M
Enterprise Value	421.26M

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, before market open.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

ESPR has 196.22 million shares outstanding. The number of shares has increased by 76.93% in one year.

Shares Outstanding	196.22M
Shares Change (YoY)	+76.93%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	0.71%
Owned by Institutions (%)	70.49%
Float	194.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.91
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.52
EV / EBITDA	84.42
EV / EBIT	85.14
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.97

Current Ratio	1.97
Quick Ratio	1.42
Debt / Equity	n/a
Debt / EBITDA	46.08
Debt / FCF	n/a
Interest Coverage	0.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	1.05%
Return on Capital (ROIC)	8.16%
Revenue Per Employee	$1.16M
Profits Per Employee	-$410,404
Employee Count	240
Asset Turnover	0.95
Inventory Turnover	1.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.88% in the last 52 weeks. The beta is 1.00, so ESPR's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	+34.88%
50-Day Moving Average	2.03
200-Day Moving Average	2.26
Relative Strength Index (RSI)	43.57
Average Volume (20 Days)	3,110,707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ESPR had revenue of $277.79 million and -$98.50 million in losses. Loss per share was -$0.68.

Revenue	277.79M
Gross Profit	169.78M
Operating Income	4.95M
Pretax Income	-98.50M
Net Income	-98.50M
EBITDA	4.99M
EBIT	4.95M
Loss Per Share	-$0.68

Full Income Statement

Balance Sheet

The company has $189.30 million in cash and $269.14 million in debt, giving a net cash position of -$79.83 million or -$0.41 per share.

Cash & Cash Equivalents	189.30M
Total Debt	269.14M
Net Cash	-79.83M
Net Cash Per Share	-$0.41
Equity (Book Value)	-344.22M
Book Value Per Share	-1.77
Working Capital	169.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.76 million and capital expenditures -$150,000, giving a free cash flow of -$9.91 million.

Operating Cash Flow	-9.76M
Capital Expenditures	-150,000
Free Cash Flow	-9.91M
FCF Per Share	-$0.05

Full Cash Flow Statement

Margins

Gross margin is 61.12%, with operating and profit margins of 1.78% and -35.46%.

Gross Margin	61.12%
Operating Margin	1.78%
Pretax Margin	-35.46%
Profit Margin	-35.46%
EBITDA Margin	1.80%
EBIT Margin	1.78%
FCF Margin	-3.57%

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-76.93%
Shareholder Yield	-76.93%
Earnings Yield	-28.85%
FCF Yield	-2.90%

Analyst Forecast

The average price target for ESPR is $8.17, which is 369.54% higher than the current price. The consensus rating is "Buy".

Price Target	$8.17
Price Target Difference	369.54%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	63.73%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -4.5 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.5
Piotroski F-Score	5